Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exparel for Postsurgical Analgesia in Laparoscopic Bariatric Surgery
NCT02969187Phase 4Completed
- Sponsor
- Cleveland Clinic
- Start
- Nov 2016
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain, sponsored by Cleveland Clinic. Primary endpoint: Total Amount of Opioids at 48 hours. Started Nov 2016; status: completed.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02969187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02969187.